Pulmonary Function Testing Devices Market to Reach $3.5 Billion, Globally, by 2031 at 6.4% CAGR: Allied Market Research

Rise in the prevalence of lung cancer and lung-related disorders, increased demand for minimally invasive tests for lung diseases, and surge in R&D activity for pulmonary function testing devices drive the global pulmonary function testing devices market.

PORTLAND, Ore., Sept. 26, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Pulmonary Function Testing Devices Market by Product (Portable PFT Devices, Complete PFT Devices), by Test Type (Spirometry, Peak flow meter, Lung Volume Test, Gas Exchange Testing, Maximal Voluntary Ventilation, Others), by Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, Others), by End user (Hospital, Clinical laboratories, Diagnostic Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global pulmonary function testing devices market industry generated $1.9 billion in 2021, and is estimated to reach $3.5 billion by 2031, witnessing a CAGR of 6.4% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.

Download Free Sample Report (235 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/3749

Drivers and Opportunities

Rise in the prevalence of lung cancer and lung-related disorders, surge in the geriatric population, increase in the adoption of technologically advanced medical devices worldwide, spike in the demand for minimally invasive tests for lung diseases, growing R&D activity for pulmonary function testing devices, and mounting healthcare expenditures drive the growth of the global pulmonary function testing devices market. However, the high cost of medical devices and a lack of awareness regarding pulmonary tests among patients hamper the market growth. On the other hand, the emerging healthcare market in developing countries offer lucrative growth opportunity for the market.

Covid-19 Scenario

• The outbreak of the Covid-19 pandemic has a positive impact on the growth of the pulmonary function testing devices market.
• Coronavirus causes a detrimental effect on the lungs. Hence, the demand for medical equipment or device increased during the pandemic owing to surge in demand for pulmonary test to diagnose the disease or check the efficacy of the lungs.
• Furthermore, the demand for pulmonary function test (PFT) tool also increased during the pandemic as it is a valuable tool for assessing respiratory diseases. Spirometry is the key diagnostic test for airway diseases such as asthma and chronic obstructive pulmonary disease (COPD), and is the most commonly performed test.

The portable PFT devices market segment to rule the roost during the forecast period

Based on product, the portable PFT devices segment was the largest market in 2021, contributing to nearly three-fifths of the global pulmonary function testing devices market, and is expected to maintain its leadership status during the forecast period. Moreover, the same segment is projected to witness the largest CAGR of 6.8% from 2022 to 2031. The growth of the segment is attributed to the rise in the prevalence of lung cancer and other lung-related disorders which increases the demand for non-invasive tests that measure the capacity of lungs.

Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/3749

The spirometry segment to maintain its dominance during the forecast period

Based on test type, the spirometry segment held the largest market share of nearly two-thirds of the global pulmonary function testing devices market in 2021, and is expected to maintain its dominance during the forecast period. Moreover, the same segment is projected to witness the largest CAGR of 7.0% from 2022 to 2031. The growth of the segment is due to an increase in the prevalence of asthma and other lung-related disorders across the world.

The chronic obstructive pulmonary disease segment to maintain its dominance during the forecast period

Based on application, the chronic obstructive pulmonary disease segment held the largest market share of nearly two-fifths of the global pulmonary function testing devices market in 2021, and is expected to maintain its dominance during the forecast period. Moreover, the same segment is projected to witness the largest CAGR of 7.3% from 2022 to 2031. This is due to the rise in the geriatric population and an increase in the prevalence of COPD among adults.

North America to dominate the market by 2031

Based on region, North America was the largest market in 2021, capturing around two-fifths of the global pulmonary function testing devices market, and is expected to lead the trail during the forecast period, owing to the increase in healthcare expenditure and the presence of major players in the region. However, Asia-Pacific is projected to manifest the fastest CAGR of 7.4% during the forecast period, owing to a rise in the prevalence of chronic diseases and an increase in the geriatric population in developing countries such as India and China.

Leading Market Players

• Chest M.I Inc.
• Clarity Medical Pvt. Ltd.
• Cosmed srl
• Data Sciences International Inc.
• Eco Medics AG
• Geratherm Medical AG
• JK Medical System Pvt. Ltd.
• Medical Electronic Construction
• Medical Equipment Europe GmbH
• MGC Diagnostics Corporation
• Morgan Scientific Inc.
• NDD Medical Technologies Inc.
• Omron Corporation
• Pulm One Advanced Medical Devices Ltd.
• Schiller AG
• Koko LLC
• Vyaire Medical Inc.

The report provides a detailed analysis of these key players of the global pulmonary function testing devices market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Dermatologicals Market by Disease (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia, and Others), Type (Prescription-based Drugs, and Over-the-Counter Drugs), and Route of Administration (Topical Administration, Oral Administration, and Parenteral Administration): Global Opportunity Analysis and Industry Forecast, 2021--2030

U.S. Healthcare IT Market By Product Type (Healthcare Provider Solutions, Healthcare Payer Solutions, and HCIT Outsourcing Services) and End User (Healthcare Providers and Healthcare Payers) : Opportunity Analysis and Industry Forecast, 2021-2030

Genetic Testing Market by Type (Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), Application (Cancer diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027

Cell Therapy Market by Cell Type (Stem Cell and Non-Stem Cell), Therapy Type (Autologous and Allogenic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), and End User (Hospitals & Clinics and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2027

Drug Discovery Services Market by Process (Target Selection, Target Validation, Hit-to-lead Identification, Lead Optimization, Candidate Validation, and Others), Type (Medicinal Chemistry, Biological Services, Drug Metabolism, Pharmaceutical Services, and Pharmacokinetics), Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, and Diabetes & Others), Drug Type (Small Molecules and Biologics), Technology (High-throughput Screening, Biochips, Pharmacogenetics, Nanotechnology, and Spectroscopy), and End User (Hospital & Clinics, Pharmaceutical Companies, Biotechnology Companies, and Research Institute): Global Opportunity Analysis and Industry Forecast, 2018-2025

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on Blog: https://www.globalhealthcareindustry.com/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg